Latest literature | Zhongnan Medical Journal Press

Home Literature Latest literature

Latest literature

Analysis of depression burden and attribution risk factors among Chinese adolescents aged 10~24 from 1990 to 2021

Published on New Medicine 2025,35(9):1033-1040.
28596 times 2589 times

LIU Jing XU Bin AN Jingrong·An Zhiguo WU Ruikai Gao Shuaishuai

Depression Teenagers Disease burden Attributing risk factors Forecast The global burden of disease
Details
Analysis of the disease burden of breast cancer in Sinosphere countries from 1990 to 2021

Published on New Medicine 2025,35(9):1024-1032.
12514 times 1761 times

HUANG Haihua HE Qiqiang

Breast cancer Disability-adjusted life years Sinosphere countries Incidence Mortality Disease burden
Details
Prediction of incidence and mortality rates of nasopharyngeal carcinoma in China from 2022 to 2026: based on GM(1,1) and ARIMA models

Published on New Medicine 2025,35(9):1017-1023.
16643 times 2144 times

LIN Xiaolong ZHANG Jie LIN Wei

Nasopharyngeal cancer GM(1 1) model ARIMA model Incidence rate Mortality rate
Details
Relationship between serum NF-κB, CXCL13, ADAM17 levels and prognosis in children with primary immune thrombocytopenia

Published on New Medicine 2025,35(9):1011-1016.
13294 times 1700 times

CHEN Lan PI Cai GAO Hui XIONG Wen YANG Dan

Primary immune thrombocytopenia Children NF-κB CXCL13 ADAM17 Prognosis
Details
The association between sleep duration, overweight/obesity, and multimorbidity among primary care medical staff

Published on New Medicine 2025,35(9):1004-1010.
14295 times 1881 times

JIANG Hong LEI Haoyuan GENG Hui HE Dandan ZHANG Yanxiu MA Mao

Multimorbidity Sleep duration Overweight/obesity Medical staff of primary health service institutions
Details
Effect of discharge preparation services based on IMB model in patients undergoing metabolic and bariatric surgery

Published on New Medicine 2025,35(9):996-1003.
12990 times 1838 times

FANG Shu ZHANG Cheng LI Zhen DU Li

Obesity Metabolic and bariatric surgery Information-motivation-behavior model Discharge preparation service
Details
Research on machine learning model-assisted screening of high-risk tumor surgery patients and the effectiveness of pre-admission management

Published on New Medicine 2025,35(9):987-995.
12361 times 1937 times

GONG Yuhong SHANG Nan HE Yasha ZHANG Shaoguo WANG Wentian YANG Zhuang YANG Lulu LIU Yanmei GAO Hongmei ZHAO Jingyuan ZHOU Peibin

Pre-admission model Length of stay Hospitalization costs Propensity score matching Machine learning High-risk tumor patients
Details
Treatment and monitoring of a case of suppurative arthritis complicated with sepsis secondary to tophi rupture

Published on Chinese Journal of Pharmacoepidemiology 2025,34(10):1213-1218.
9423 times 1990 times

MA Hongyan XU Gengrui HUANG Kaiyuan WANG Xiaokang WU Haidong DENG Kai XIE Peitao

Gout stones Suppurative arthritis Sepsis Pharmaceutical care Methicillin-sensitive Staphylococcus aureus
Details
Research progress on new dosage forms and new technology for the formulation of the insoluble drug aprepitant

Published on Frontiers in Pharmaceutical Sciences 2025,29(8):1431-1440.
10123 times 1872 times

ZHANG Tao LUO Yu ZHANG Xu WANG Deyan WANG Qianru XU Yuan HU Taomin GAO Xiurong

Aprepitant Nausea and vomiting New dosage forms New technology in formulation
Details
Research progress on the role and mechanism of Chitooligosaccharides in improving metabolic dysfunction-associated fatty liver disease

Published on Frontiers in Pharmaceutical Sciences 2025,29(8):1422-1430.
9041 times 1658 times

ZHONG Li HUANG Guidong

Chitooligosaccharides Metabolic dysfunction-associated fatty liver disease Lipid-Lowering mechanism Research progress
Details
Progress in the study of Chinese medicine for the treatment of gout

Published on Frontiers in Pharmaceutical Sciences 2025,29(8):1412-1421.
16537 times 2211 times

WANG Yunqing LI Gang LIU Jiang

Gout Chinese medicine treatment Ethnomedicine Research progress Review
Details
Research progress on biosynthesis of Panaxnotoginseng saponins

Published on Frontiers in Pharmaceutical Sciences 2025,29(8):1404-1411.
10753 times 1915 times

HAN Jingjie LOU Yuefen

Panaxnotoginseng saponins Biosynthesis Key enzymes Chassis cell Regulatory strategy
Details
Visual analysis for radiation protection of flavonoids based on CiteSpace

Published on Frontiers in Pharmaceutical Sciences 2025,29(8):1393-1403.
8519 times 1783 times

LIU Yang LI Tingyang LI Yiliang LI Jiahui TAO Ming SHANG Haihua HOU Wenbin

Flavonoids Radiation protection CiteSpace Visual analysis Bibliometrics Radioprotectants
Details
Clinical observation of omadacycline in treating elderly patients with chronic obstructive pulmonary disease complicated by community-acquired bacterial pneumonia

Published on Frontiers in Pharmaceutical Sciences 2025,29(8):1385-1392.
8889 times 1761 times

YANG Feiyan YANG Guobiao ZHANG Ya YANG Jianye XU Mengmin

Omadacycline Chronic obstructive pulmonary disease Community-acquired bacterial pneumonia Clinical efficacy
Details
Efficacy and immune mechanism of microbiota transplantation combined with deep hyperthermia in patients with malignant pleural and peritoneal effusion

Published on Frontiers in Pharmaceutical Sciences 2025,29(8):1376-1384.
8164 times 1698 times

FU Yazhai TANG Xiaowan YANG Haihua

Deep hyperthermia Malignant pleural and peritoneal effusion Microbiota transplantation Immunomodulation Tumour necrosis factor αlpha
Details
Signal mining and analysis of brinzolamide-associated adverse events based on the FAERS database

Published on Frontiers in Pharmaceutical Sciences 2025,29(8):1368-1375.
8326 times 1780 times

CHEN Ayin JIANG Hui GAO Liang

Brinzolamide Adverse drug events FAERS database glaucoma
Details
Tetrahydropalmatine activates the Nrf2/ARE pathway to alleviate oxidative stress and improve high glucose-induced insulin resistance in HepG2 cells

Published on Frontiers in Pharmaceutical Sciences 2025,29(8):1360-1367.
9022 times 1752 times

YE Xiaoting CHEN Xiaohai XU Shuang

Tetrahydropalmatine HepG2 Insulin resistance Nrf2/ARE Oxidative stress
Details
Imbalance analysis and signal evolution map of olanzapine pharmacovigilance based on evidence from the FAERS database

Published on Frontiers in Pharmaceutical Sciences 2025,29(8):1352-1359.
9802 times 1935 times

YAN Fuyang LI Yang DU Chengrong XIA Lehong

Olanzapine Adverse drug events FAERS Schizophrenia Pharmacovigilance
Details
Construction of a prediction model for medication non-adherence of anti- parkinsonian drugs in patients with Parkinson's disease

Published on Frontiers in Pharmaceutical Sciences 2025,29(8):1343-1351.
8909 times 1687 times

JI Yuanyuan ZHANG Xiaobei [FLJ

Parkinson's disease Medication adherence Influencing factors Prediction model
Details
Influence of external application of modified Qingliang Huohua powder at different temperatures on patients with damp-heat accumulation type of knee osteoarthritis

Published on Frontiers in Pharmaceutical Sciences 2025,29(8):1336-1342.
9351 times 1764 times

SHU Qiongyan YE Haixia FENG Yanqin WANG Jian ZHAO Wanjun WANG Junjie

Modified qingliang huohua powder Knee osteoarthritis Temperature External application Damp-heat accumulation type
Details